LONDON — October 7, 2025 — Leads & Copy — Optimum Strategic Communications is hosting its 17th Annual Healthcare Investor Conference on Thursday, October 9, 2025, at The Kings Fund in London. The conference will address how companies with promising science can secure capital to develop drugs, and how pharma companies can fill pipelines amidst patent cliffs. Industry leaders will discuss resilience in a year marked by health policy shifts and market turbulence.
Optimum’s ‘Investor speed dating’ morning will return by popular demand, connecting early-stage companies with life sciences investors. Mary Clark, CEO of Optimum Strategic Communications, noted that despite tough market conditions, many companies are still growing. Optimum has advised on 28 financing rounds, 33 deals, and over 50 clinical milestones in the past year.
Panellists will discuss effective exit strategies, next-generation venture capitalists will talk about reshaping the life sciences landscape, and industry experts will explore navigating challenging market conditions and provide insights for 2026.
Brain Tumour Research is the featured charity for this year’s conference. The charity aims to increase UK investment into brain tumour research to find cures for all types of brain tumours, as brain tumours kill more children and adults under 40 than any other cancer, yet receive only 1% of the UK’s national spend on cancer research.
For more information, visit: IR Conference 2025 – Optimum Strategic Communications
Contact:
[Contact information not provided in the press release]
Source: Optimum Strategic Communications
